Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Research And Development Expense of $84.45 million for the year ending 2025.
- CAPRICOR THERAPEUTICS, INC. showed an increase of +69.0% in Research And Development Expense from 2024 to 2025.
- This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $702.9 thousand | Q3 2011: $1.47 million | Q1 2012: $465.4 thousand | Q2 2012: $332.5 thousand | Q3 2012: $179.1 thousand | Q1 2013: $1.19 million | Q2 2013: $1.31 million | Q3 2013: $1.01 million | Q1 2014: $1.37 million | Q2 2014: $1.86 million | Q3 2014: $1.97 million | Q1 2015: $3.81 million | Q2 2015: $3.43 million | Q3 2015: $3.19 million | Q1 2016: $4.34 million | Q2 2016: $4.31 million | Q3 2016: $4.73 million | Q1 2017: $3.26 million | Q2 2017: $3.13 million | Q3 2017: $1.86 million | Q1 2018: $2.70 million | Q2 2018: $3.39 million | Q3 2018: $3.13 million | Q1 2019: $1.81 million | Q2 2019: $1.64 million | Q3 2019: $857.8 thousand | Q1 2020: $1.16 million | Q2 2020: $1.93 million | Q3 2020: $2.63 million | Q1 2021: $3.30 million | Q2 2021: $3.50 million | Q3 2021: $2.51 million | Q1 2022: $5.12 million | Q2 2022: $4.97 million | Q3 2022: $5.50 million | Q1 2023: $7.66 million | Q2 2023: $8.82 million | Q3 2023: $10.03 million | Q1 2024: $11.10 million | Q2 2024: $12.50 million | Q3 2024: $11.81 million | Q1 2025: $18.92 million | Q2 2025: $22.05 million | Q3 2025: $20.36 million.
- Over the full 16 years of available data (2010 to 2025), CAPRICOR THERAPEUTICS, INC.'s Research And Development Expense has grown by 1,969.5%.
- Historical annual values: Fiscal year 2025: $84.45 million | Fiscal year 2024: $49.97 million | Fiscal year 2023: $36.45 million | Fiscal year 2022: $21.82 million | Fiscal year 2021: $13.57 million | Fiscal year 2020: $8.46 million | Fiscal year 2019: $5.14 million | Fiscal year 2018: $12.07 million | Fiscal year 2017: $10.77 million | Fiscal year 2016: $16.04 million | Fiscal year 2015: $13.76 million | Fiscal year 2014: $7.79 million | Fiscal year 2013: $5.20 million | Fiscal year 2012: $2.63 million | Fiscal year 2011: $4.14 million | Fiscal year 2010: $4.08 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: